Gum treatment review finds modest biomarker changes, with weak evidence
An umbrella review reported lower C-reactive protein and LDL cholesterol and higher HDL cholesterol, while other cardiovascular markers gave inconsistent results.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Nonsurgical gum treatment was associated with modest changes in some cardiovascular risk markers among adults with periodontitis. The pooled results reported lower C-reactive protein and LDL cholesterol and higher HDL cholesterol. Most evidence was weak or nonsignificant, and these laboratory changes do not establish that treatment prevents heart attacks or other cardiovascular events.
The authors identified substantial differences between studies, high risk of bias and overlapping evidence across reviews. The abstract also leaves treatment comparators and follow-up durations unspecified, limiting interpretation of the pooled changes.
The outcomes were risk markers
The review focused on blood markers and vascular measurements. Those outcomes can describe changes after treatment, but the abstract does not report cardiovascular event outcomes or demonstrate how the biomarker differences translate into patient benefit.
The evidence was uneven
The conclusion describes a wider set of marker benefits than the results quantify. Other markers and vascular measurements showed inconsistent results, and the authors judged much of the evidence weak because of methodological problems.
The original publication
Does non-surgical periodontal therapy improve biomarkers associated with cardiovascular disease? An umbrella review.
Shi R, Jamieson L, Nath S
Clin Oral Investig · 2025
- PubMed ID
- 41372459
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.